GS3 007
Alternative Names: GS3-007; GS3-007ALatest Information Update: 30 Jun 2023
At a glance
- Originator GeneScience Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 19 Jun 2023 GeneScience Pharmaceuticals plans a phase I trial (in volunteers) in China (PO, Liquid) (NCT05921890)
- 22 Sep 2022 Phase-I clinical trials in Unspecified (In volunteers) in China (PO, Liquid) (NCT05611281)